[1]北京日報客戶端.北京記「疫」[EB/OL]. https://ie.bjd.com.cn/bjd/Html/20200312/0/1C5D144E6712F399_Phone.html?newsid=1C5D144E6712F399. 2003-06-25.
[2]Hin, C. , Fuk-Woo, C. J. , Yixin, W. , Tsz-Tai, Y. T. , Yue, C. , & Yuxin, H. , et al. (0). Comparative replication and immune activation profiles of sars-cov-2 and sars-cov in human lungs: an ex vivo study with implications for the pathogenesis of covid-19[J]. Clinical Infectious Diseases.
[3]World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 32 [EB/OL].https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200221-sitrep-32-covid-19.pdf?sfvrsn=4802d089_2. 2020-02-21.
[4]Chang Le,Yan Ying,Wang Lunan. Coronavirus Disease 2019: Coronaviruses and Blood Safety.[J]. Transfusion medicine reviews,2020,34(2).
[5]Roehrig John T,Hombach Joachim,Barrett Alan D T. Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses.[J]. Viral immunology,2008,21(2).
[6]Pastorino Boris,Touret Franck,Gilles Magali,Luciani Lea,de Lamballerie Xavier,Charrel Remi N. Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples.[J]. Viruses,2020,12(6).
[7]Doremalen, N. V. , Bushmaker, T. , Morris, D. H. , Holbrook, M. G. , & Munster, V. J. . (2020). Aerosol and surface stability of sars-cov-2 as compared with sars-cov-1[J]. New England Journal of Medicine, 382(16).